Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients
Eva Camgrand, Brefel-Courbon Christine, Estelle Harroch, Cécile Chouquet, Christel Barthélémy, Fabienne Ory‐Magne, Clémence Leung, Raquel Barbosa, Olivier Rascol, Margherita Fabbri
Topics & Concepts
ApomorphineDiscontinuationParkinson's diseaseMedicineLevodopaPlaceboAdverse effectPsychologyDiseaseAnesthesiaInternal medicineDopamineDopaminergicPathologyAlternative medicineParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBotulinum Toxin and Related Neurological Disorders